Cognex (NASDAQ:CGNX) Releases FY 2026 Earnings Guidance

Cognex (NASDAQ:CGNX) updated its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 1.640-1.680 for the period, compared to the consensus EPS estimate of 1.480. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion. Cognex also updated its Q3 2026 guidance to 0.500-0.540 EPS.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on CGNX shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Cognex in a report on Friday, May 15th. The Goldman Sachs Group restated a “buy” rating and set a $91.00 target price on shares of Cognex in a research report on Friday. Stephens upped their target price on Cognex from $65.00 to $75.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Cantor Fitzgerald increased their price target on Cognex from $76.00 to $84.00 and gave the stock an “overweight” rating in a report on Friday. Finally, Seaport Research Partners set a $75.00 price target on Cognex in a research note on Tuesday, May 26th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $75.69.

Cognex Price Performance

NASDAQ CGNX traded down $0.07 on Friday, hitting $67.31. The stock had a trading volume of 978,220 shares, compared to its average volume of 2,213,192. The business’s fifty day moving average price is $64.99 and its 200 day moving average price is $57.09. The stock has a market cap of $11.20 billion, a price-to-earnings ratio of 65.41 and a beta of 1.49. Cognex has a 52-week low of $34.60 and a 52-week high of $72.88.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.42 by $0.03. The firm had revenue of $291.26 million during the quarter, compared to analysts’ expectations of $292.10 million. Cognex had a return on equity of 13.82% and a net margin of 16.05%.The business’s quarterly revenue was up 16.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.25 EPS. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, sell-side analysts anticipate that Cognex will post 1.48 EPS for the current year.

Cognex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be given a dividend of $0.085 per share. The ex-dividend date is Thursday, August 20th. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. Cognex’s payout ratio is currently 40.48%.

Insider Buying and Selling at Cognex

In other news, VP Darren Marc Long sold 20,252 shares of the business’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total value of $1,343,517.68. Following the completion of the transaction, the vice president owned 3,990 shares of the company’s stock, valued at $264,696.60. The trade was a 83.54% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Laura Ann Macdonald sold 98,122 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $66.80, for a total value of $6,554,549.60. Following the completion of the transaction, the vice president directly owned 5,258 shares of the company’s stock, valued at $351,234.40. The trade was a 94.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 224,847 shares of company stock worth $14,975,098. Insiders own 1.70% of the company’s stock.

Cognex News Roundup

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Strong earnings and outlook: Second-quarter EPS was $0.45, above the $0.42 consensus and up from $0.25 a year ago. Revenue rose 16.9% year over year to approximately $291 million, while net income increased 78% to $72.8 million. Cognex Corporation Tops Q2 Earnings Estimates
• Positive Sentiment: Guidance exceeded expectations: Cognex forecast third-quarter revenue of $300 million to $320 million and EPS of $0.50 to $0.54, well above consensus estimates of $279.2 million and $0.37, respectively. Full-year EPS guidance was raised to $1.64-$1.68, versus the prior consensus of $1.48. Cognex Q2 Earnings Beat on Margin Gains Despite Revenue Miss
• Positive Sentiment: Growth catalysts and analyst support: Management highlighted AI-enabled machine vision, data-center demand, customer expansion and improving margins. Cantor Fitzgerald, Needham and Truist raised their price targets to $84, $80 and $78, respectively; Cantor and Needham maintained bullish ratings. Cognex Q2 Earnings Call Centers on AI and Data Center Growth
• Neutral Sentiment: Cognex declared a quarterly dividend of $0.085 per share, payable September 3 to shareholders of record on August 20. The approximately 0.5% yield is modest but reinforces shareholder returns.
• Negative Sentiment: Quarterly revenue narrowly missed the roughly $292.1 million consensus estimate, and CGNX trades at an elevated trailing P/E of about 65. Recent disclosures also showed insider sales without reported purchases, which may weigh on sentiment.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of CGNX. Geneos Wealth Management Inc. grew its position in shares of Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after purchasing an additional 736 shares during the period. CIBC Private Wealth Group LLC increased its stake in Cognex by 74.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after buying an additional 327 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in Cognex during the 4th quarter worth approximately $39,000. Meeder Asset Management Inc. acquired a new position in shares of Cognex during the fourth quarter valued at approximately $47,000. Finally, Wexford Capital LP acquired a new position in shares of Cognex during the third quarter valued at approximately $52,000. Institutional investors and hedge funds own 88.12% of the company’s stock.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.